SKI Market

A+| A| A-|

Indian Indices

Sensex

76,755.05 -715.06
( -0.92%)

Global Indices

Nasdaq

52,245.67 385.41
(0.74%)

Dow Jones

7,529.66 65.38
(0.88%)

Hang Seng

66,164.55 -67.64
(-0.10%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.43 0.01
(0.01%)

EUR-INR

110.17 -0.09
(-0.08%)

GBP-INR

129.67 0.03
(0.02%)

JPY-INR

0.59 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter

Feb 12,2026

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	53.81	56.17	-4
OPM %	11.43	15.54	-
PBDT	6.53	9.06	-28
PBT	5.60	8.25	-32
NP	4.43	5.96	-26

76,755.05 -715.06 ( -0.92%)

52,245.67 385.41 (0.74%)

7,529.66 65.38 (0.88%)

66,164.55 -67.64 (-0.10%)

10,580.59 55.83 (0.53%)

96.43 0.01 (0.01%)

110.17 -0.09 (-0.08%)

129.67 0.03 (0.02%)

0.59 0.00 (0.01%)